Looking for work but struggling to land a job interview? Money might help. Some job seekers are paying recruiters to help get a foot in the door, a practice known as "reverse recruitment" in which ...

Retrospective ONCare Alliance Network data showed lower odds of new or worsened hypertension with acalabrutinib versus ibrutinib (OR 0.27; 95% CI, 0.074–0.98). Despite older age and higher baseline ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

At first glance, some of the language looks familiar. A letter sent to state officials in Rhode Island by the Justice Department in June included a reminder that federal civil rights law "prohibits an ...

Please provide your email address to receive an email when new articles are posted on . In the BRUIN CLL-313 trial, researchers compared pirtobrutinib (Jaypirca, Eli Lilly & Co.) vs. bendamustine plus ...

Jaypirca improved progression-free survival in CLL/SLL patients compared to bendamustine plus rituximab, reducing disease progression or death risk by 80%. This non-covalent BTK inhibitor offers a ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...